Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote "FOR" Proposed Transaction with Assertio Holdings, Inc. Phosphate Investing
Nutrien Announces Release Dates for Second Quarter 2023 Results and Conference Call Phosphate Investing
Nevada Organic Phosphate Enters into Contract for Investor Relations Services and Appoints New Corporate Secretary Phosphate Investing
Spectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement Phosphate Investing
